Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
CAS No. : | 186593-42-0 | MDL No. : | MFCD08688606 |
Formula : | C6H5BrN2O2 | Boiling Point : | No data available |
Linear Structure Formula : | - | InChI Key : | QWAOQTGMEGSRLN-UHFFFAOYSA-N |
M.W : | 217.02 | Pubchem ID : | 18458822 |
Synonyms : |
|
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | With caesium carbonate; 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene;tris-(dibenzylideneacetone)dipalladium(0); In toluene; at 90℃; for 16h;Inert atmosphere; | EXAMPLE 1:4-((4-ethylpiperazin-l-yl)methyl)-N-(6-methyl-5-(4-(pyridin-3-yl)pyrimidin-2- ylamino)pyridin-3-yl)benzamide(a) (2-Methyl-5-nitro-pyridin-3-yl)-(4-pyridin-3-yl-pyrimidin-2-yl)-amine[0121] To a mixture of 3-bromo-2-methyl-5-nitro-pyridine (380mg, 1.75mmol) and 4-pyridin-3-yl-pyrimidin-2-ylamine (250mg, 1.45mmol) in dry toluene (2OmL) were added Cs2CO3 (710mg, 2.18mmol), Pd2(dba)3 (26mg, 0.028mmol) and Xantphos (50mg, 0.086mmol). The mixture was evacuated and purged with N2 (3 cycles), heated to 9O0C under N2 for 16h. After completion (monitored by TLC), the reaction mixture was cooled to rt, diluted with EtOAc and filtered. The filtrate was concentrated under reduced pressure and the residue was purified by column chromatography (SiO2) using CH2Cl2-MeOH (98:2) to afford product (225mg, 50percent). 1H NMR (200 MHz, CDCl3): delta 2.76 (s, 3H), 7.23 (m, IH), 7.38 (d, J= 6.0 Hz, IH), 7.51 (m, IH), 8.51 (m, IH), 8.63 ( d, J= 6.0 Hz, IH), 8.77 (m, IH), 9.04 (d, J= 2.0 Hz, IH), 9.28 (d, J= 2.0 Hz, IH), 9.77 (d, J= 2.0 Hz, IH); Mass [M+H]+: 309. |
[ 69872-15-7 ]
3-Bromo-4-methyl-5-nitropyridine
Similarity: 0.81
[ 186413-75-2 ]
3-Bromo-6-chloro-2-methyl-5-nitropyridine
Similarity: 0.79
[ 2229221-49-0 ]
2-(2-Bromoethyl)-5-nitropyridine
Similarity: 0.79
[ 186593-43-1 ]
5-Amino-3-bromo-2-methylpyridine
Similarity: 0.79
[ 69872-15-7 ]
3-Bromo-4-methyl-5-nitropyridine
Similarity: 0.81
[ 186413-75-2 ]
3-Bromo-6-chloro-2-methyl-5-nitropyridine
Similarity: 0.79
[ 2229221-49-0 ]
2-(2-Bromoethyl)-5-nitropyridine
Similarity: 0.79
[ 69872-15-7 ]
3-Bromo-4-methyl-5-nitropyridine
Similarity: 0.81
[ 186413-75-2 ]
3-Bromo-6-chloro-2-methyl-5-nitropyridine
Similarity: 0.79
[ 2229221-49-0 ]
2-(2-Bromoethyl)-5-nitropyridine
Similarity: 0.79